The Business of Chronicity: Clients, not Patients

The Cure is a Bad Business

In the current financial system, a cured patient is a lost client. The global pharmaceutical industry generates trillions of dollars annually thanks to diseases that never quite disappear, but are “managed”. The goal is not health, but biological customer loyalty.

“If you can sell someone a daily pill for 40 years, why would you sell them an injection that heals them in one day?”

The Symptom Management Model

Modern medicine has been redirected to attack the symptom, never the root.

• The Suppression of Innovation: There are records of patents and alternative treatments that mysteriously disappear or are discredited by “committees of experts” funded by the same companies that sell the palliative.
• Cascading Side Effects: The drug for problem A creates problem B, which requires drug C. In the end, the individual becomes a walking polypharmacy, trapped in a loop of chemical dependency.

The Flexner Report and the Hijacking of Medicine

In the early 20th century, medical education was standardized (and funded) by the Rockefeller and Carnegie foundations. Any nutritional or preventive approach was eliminated to focus exclusively on petrochemical pharmacology. Whoever controls the doctor’s training, controls the hand that signs the prescription.

Diet as Phase One

For the pharmaceutical business to thrive, a chronically ill population baseline is needed. The food industry (processed foods, sugars, glyphosate) paves the way, creating deficiencies and chronic inflammatory processes that Big Pharma takes charge of “keeping under control”. It is a perfectly synchronized system: some make you sick, others keep you alive just enough so you keep paying.

[ END OF TRANSMISSION ]